Regulating a Damage Repair Approach to Cure the Diseases of Aging - Panel Discussion
Escalating societal healthcare needs have driven an unprecedented era of biomedical innovation. However, the development of candidate technologies without consideration of a robust regulatory strategy is likely to contribute to stymied patient access and commercial viability. Therefore, this session considered worldwide efforts to rapidly and proportionally develop international regulatory processes to accommodate increasingly heterogeneous and unfamiliar healthcare technologies and their swift translation from lab to bedside.
- David Brindley, Research Fellow, University of Oxford/Center for the Advancement of Sustainable Medical Innovation (Moderator)
- Bob Clay, Chief Regulatory Officer, Kinapse & Manging Director, Highbury Regulatory Science
- Andrew Martello, Managing Director, Spoonful of Sugar
- Evan Snyder, Director, Center for Stem Cell and Regenerative Medicine, Director, Stem Cell Research Center and Core Facility, Sanford-Burnham Medical Research Institute